Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.4049/jimmunol.1101512

http://scihub22266oqcxt.onion/10.4049/jimmunol.1101512
suck pdf from google scholar
22450806!?!22450806

suck abstract from ncbi

pmid22450806      J+Immunol 2012 ; 188 (9): 4209-16
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5 #MMPMID22450806
  • Dilek N; Poirier N; Usal C; Martinet B; Blancho G; Vanhove B
  • J Immunol 2012[May]; 188 (9): 4209-16 PMID22450806show ga
  • Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature cells that are believed to inhibit immune responses in the contexts of cancer and organ transplantation, in association with regulatory T cells (Treg). However, the way in which MDSC cooperate with Treg remains elusive. In this study, we used DNA microarrays to analyze gene expression in blood-derived MDSC from rat recipients of kidney allografts. We found CCL5 (Rantes), a chemotactic C-C motif 5 chemokine, to be strongly downregulated after treatment with a tolerizing regimen. The amount of CCL5 protein was also lower in the plasma of tolerant recipients, whereas intragraft CCL5 was unchanged. Because CCL5 is chemotactic for Treg, we hypothesized that a gradient of CCL5 between the graft and peripheral blood might contribute to the intragraft localization of Treg in tolerant animals. To test this hypothesis, we treated tolerant rat recipients of kidney allografts with recombinant rat CCL5 to restore normal plasma concentrations. This led to a strong reduction in intragraft Treg monitored by immunohistofluorescence and by quantitative real-time PCR measurement of Foxp3 mRNA. Ultimately, this treatment led to an increase in serum creatinine concentrations and to kidney graft rejection after about a month. The kidney function of syngeneic grafts was not affected by a similar administration of CCL5. These data highlight the contribution of MDSC to the establishment of a graft-to-periphery CCL5 gradient in tolerant kidney allograft recipients, which controls recruitment of Treg to the graft where they likely contribute to maintaining tolerance.
  • |*Kidney Transplantation[MESH]
  • |*Transplantation Tolerance[MESH]
  • |*Transplants[MESH]
  • |Animals[MESH]
  • |Cell Line[MESH]
  • |Chemokine CCL5/*immunology/metabolism[MESH]
  • |Forkhead Transcription Factors/biosynthesis/immunology[MESH]
  • |Gene Expression Profiling[MESH]
  • |Gene Expression Regulation/immunology[MESH]
  • |Kidney/*immunology[MESH]
  • |Male[MESH]
  • |Mice[MESH]
  • |Myeloid Cells/*immunology/metabolism[MESH]
  • |Oligonucleotide Array Sequence Analysis[MESH]
  • |RNA, Messenger/biosynthesis/immunology[MESH]
  • |Rats[MESH]
  • |Rats, Inbred Lew[MESH]
  • |T-Lymphocytes, Regulatory/*immunology/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box